New global analysis from the WHO’s International Agency for Research on Cancer further highlights the opportunity to target ...

The success and popularity of GLP-1 receptor agonists (RAs) for the treatment of patients with diabetes and obesity has led to intense interest in other potential effects of treatment, including ...

Roughly 37–40% of all new cancer cases in 2022—about 7.1 million—were linked to preventable causes, suggesting major ...

A total of 30 modifiable risk factors account for almost 40% of new cancer cases globally, a landmark study from the World ...

Investigators reviewed medical literature to determine the prevalence of breast cancer screening among female survivors of a prior cancer other than breast cancer and to compare the likelihood of ...

The 30 controllable risk factors that fuel cancer, researchers identify - Preventable cancer is more common in men than women ...

A landmark global study suggests that tobacco smoking, infection and alcohol consumption are the leading causes of ...

Find out more about favourable imaging techniques in mortality rates and early detection among survivors of breast cancer.

Metastasis-directed therapy (MDT) delivered via stereotactic body radiotherapy has gained substantial attention over the past decade. Landmark trials such as STOMP1 and ORIOLE2 fundamentally shifted ...